Researchers in Europe are predicting that nearly all men over the age of 55 may start taking a statin to lower their cholesterol if new heart health guidelines in the U.S. go into effect, which may ignite more Lipitor lawsuit filings.
According to a recent study in the Journal of the American Medical Association (JAMA), regulations set forth last year by the American College of Cardiology and the American Heart Association may significantly impact countries outside the U.S. The new guidelines direct doctors to prescribe only statin medications to individuals with high cholesterol and to throw out goals related to cholesterol goals. As a result, some patients may be on a particular medication permanently. Among other things, the JAMA research found that if doctors in Europe follow these recommendations, statins may be given to 96.4% of men and 65.8 percent of women older than 55. The mean age of these participants was shown to be 65.5, according to the study, which looked at 4,854 participants used in research in Rotterdam from 1997 to 2001.
This prediction is particularly troubling given the side effects that have recently been associated with statin medications. As of March 2014, court records show at least 270 Lipitor diabetes lawsuits filed in a federal litigation established in the U.S. District Court, District of South Carolina on behalf of patients who claim to have developed diabetes after taking the drug from Pfizer, Inc.
All the Lipitor lawsuits in this litigation involve claims that accuse Pfizer of marketing a product they knew had an association with the disease, but concealed information from the public in order to further sales. According to claims over the cholesterol drug, the warnings on Lipitor’s labeling continue to remain insufficient after a mandate from the U.S. Food and Drug Administration (FDA) in February 2012 required all statin manufacturers to note their risk for diabetes.
This FDA order was prompted by findings that use of Lipitor and other drugs may increase the risk for this side effect in post-menopausal women. This research was originally published in January 2012 in JAMA: Internal Medicine.
Call our Firm today to learn more about the alleged association between Lipitor and diabetes, and to find out if you are eligible to pursue a claim against Pfizer at .